Clinical trial
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
NCT05015764 is registered in ClinicalTrials.gov with Reprieve Cardiovascular, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
- Lead sponsor
- Reprieve Cardiovascular, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 12, 2021
- Completion date
- May 2, 2022
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.